Marker genes for regulatory T cells from human blood

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9040051
SERIAL NO

12681263

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel marker genes for the specific identification and characterization of human suppressive and/or regulatory T cells including natural, adaptive, and expanded CD4+CD25+FOXP3+ T cells in healthy individuals as well as tumor patients or patients with autoimmune diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BECTON DICKINSON AND COMPANYONE BECTON DRIVE FRANKLIN LAKES NJ 07417
UNIVERSITAET ZU KOELNKOELN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beyer, Marc Daniel Köln, DE 2 2
Hingorani, Ravi San Diego, US 1 2
Schultze, Joachim Ludwig Königswinter, DE 2 2
Warner, Noel Los Gatos, US 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 26, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00